CAR-T Meeting 2020 | Academic vs. commercial CAR T-cell products
Arnon Nagler
• 30 Jan 2020
Arnon Nagler, MD, Sheba Medical Center, Tel-Aviv, Israel, compares academic and commercial CAR T-cell products. Academic products give more flexibility to treat patients and have a lower cost, but from the regulatory perspective, commercial products may be preferable. Prof. Nagler believes there is room for both academic and commercial CAR T-cell products. This interview took place at the 2nd European CAR T-Cell Meeting in Sitges, Spain.
